Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
03 May 2023
// BUSINESSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-to-present-at-the-frontiers-in-cancer-immunotherapy-2023-invited-by-new-york-academy-of-sciences-301814245.html
09 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-invitation-to-presentation-of-fourth-quarter-and-second-half-2022-results-thursday-16-february-301742895.html
05 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-appoints-stephen-worsley-as-chief-business-officer-301617678.html
25 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-second-quarter-and-first-half-of-2022-results-301612235.html
15 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-as-announces-that-an-abstract-on-ltx-315-in-combination-with-adoptive-cell-therapy-is-selected-for-a-poster-presentation-at-asco-2022-301605841.html
26 May 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lytix-biopharma-as-announces-that-an-abstract-on-ltx-315-in-combination-with-adoptive-cell-therapy-is-selected-for-a-poster-presentation-at-asco-2022-301556491.html
ABOUT THIS PAGE